透明质酸注射治疗儿童镰状细胞病肱骨头缺血性坏死
本文报告一例12岁镰状细胞病女性患者,因肱骨头及股骨头缺血性坏死导致慢性疼痛和功能障碍,在多学科疼痛管理基础上接受4次每周一次盂肱关节透明质酸注射,2个月内功能改善、阿片类药物使用减少并能参与术后康复治疗。
要点
- 儿童镰状细胞病合并肱骨头缺血性坏死可考虑关节内透明质酸注射辅助多学科疼痛管理。
- 本例12岁患者经4次每周一次盂肱关节透明质酸注射后功能改善且阿片类药物使用减少。
- 保守治疗有助于在骨骼成熟前延迟手术干预。
核心结论
- 关节内透明质酸注射可作为多学科疼痛管理计划的一部分,改善镰状细胞病相关肱骨头缺血性坏死患儿的功能并减轻疼痛。
研究设计与样本
- 个案报告:一名12岁镰状细胞病女性患者,因肱骨头及股骨头缺血性坏死接受盂肱关节透明质酸注射。
主要发现
- 患者接受4次每周一次的盂肱关节透明质酸注射。
- 2个月内患者身体功能改善、阿片类药物使用减少,并能参与所有术后治疗。
关键数值与推荐
- 盂肱关节透明质酸注射方案为4次每周一次。
临床怎么用
- 对镰状细胞病相关肱骨头缺血性坏死患儿,可在多学科疼痛管理框架下考虑盂肱关节透明质酸注射以改善功能和疼痛。
- 保守治疗可用于在骨骼成熟前延迟手术干预。
局限性
- 本文为单例个案报告,结论需未来研究评估镰状细胞病相关缺血性坏死中透明质酸注射的长期获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Avascular necrosis (AVN) can impact up to 50% of patients with sickle cell disease (SCD) and can result in significant pain, decline in physical function and decreased quality of life. While hyaluronic acid (HA) has been used in the adult population for shoulder osteoarthritic pain, we present the first published pediatric case of HA injections in the glenohumeral joint, used to improve function and pain control. CASE PRESENTATION: The patient is a 12-year-old woman with SCD, who suffered from chronic pain due to AVN of the humeral and femoral head. Despite engaging in a multidisciplinary pain management plan, she continued to have severe decline in physical functioning and became a wheelchair user. As a result, she was scheduled for a right total hip arthroplasty, which necessitated aggressive postoperative therapies using the glenohumeral joint. To improve this pain and to facilitate postoperative recovery, the patient underwent 4 weekly HA injections into the glenohumeral joint. Over a 2-month period, the patient was able to improve physical functioning, decrease opiate use and participate in all postoperative therapies. CONCLUSION: Conservative options to improve functioning and pain are especially important in pediatric patients where it may be desirable to delay surgical interventions until skeletal maturity. Our case report demonstrates the benefits of intra-articular HA as part of a multidisciplinary pain management plan to improve function and decrease pain related to AVN of the humeral head. Future studies should assess the long-term benefits of HA injections for AVN in the setting of SCD.
引用
- Wong JY, Le S, Lo C, et al. Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head. Reg Anesth Pain Med. 2021. PMID: 34642239. doi:10.1136/rapm-2021-102842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。